The aim of this study was to evaluate the effect of promethazine on the antifungal minimum inhibitory concentrations against planktonic cells and mature biofilms of Candida tropicalis, as well as investigate its potential mechanisms of cell damage against this yeast species. Three C. tropicalis isolates (two azole-resistant and one azole-susceptible) were evaluated for their planktonic and biofilm susceptibility to promethazine alone and in combination with itraconazole, fluconazole, voriconazole, amphotericin B, and caspofungin. The antifungal activity of promethazine against C. tropicalis was investigated by performing time-kill curve assays and assessing rhodamine 6G efflux, cell size/granularity, membrane integrity, and mitochondrial transmembrane potential, through flow cytometry. Promethazine showed antifungal activity against planktonic cells and biofilms at concentrations of 64 and 128 μg/ml, respectively. The addition of two subinhibitory concentrations of promethazine reduced the antifungal MICs for all tested azole drugs against planktonic growth, reversing the resistance phenotype to all azoles. Promethazine decreased the efflux of rhodamine 6G in an azole-resistant strain. Moreover, promethazine decreased cell size/granularity and caused membrane damage, and mitochondrial membrane depolarization. In conclusion, promethazine presented synergy 
Introduction
C. tropicalis is frequently isolated from patients with candidiasis, and it currently is the first or second most frequent non-Candida albicans Candida species involved in cases of candidemia and candiduria. 1 Azole resistance in C. tropicalis has been frequently reported, 2 especially among clinical isolates, [3] [4] [5] including those showing cross-resistance to azole antifungals. Azole resistance in C. tropicalis results from the overexpression and/or mutation in the ERG11 gene that encodes the cytochrome P450 lanosterol 14α-demethylase, 6 the primary target for azoles. Furthermore, at least two families of multidrug transporters are involved in the development of azole resistance in Candida spp., 7 due to the upregulation of genes that encode the efflux proteins CDR1 and MDR1. 8, 9 In addition, alternative mechanisms, such as biofilm formation and mitochondrial defects, have also been reported as strategies to develop azole resistance in Candida spp.
10,11
Candida biofilms are one of the main leading causes of infections related to medical devices. 12 Biofilm sessile cells are less susceptible to antimicrobial drugs and host defenses, which complicates the treatment of the infection. 13 In this context, C. tropicalis biofilms show reduced susceptibility to azole drugs. 14 Thus, the search for compounds with antifungal and antibiofilm activities becomes relevant. Promethazine is a first-generation H1 receptor antagonist, with antihistamine and antiemetic effects, which belongs to phenothiazines, 15 a group of compounds known to present efflux pump inhibitory properties. 16 Some studies have evaluated the antifungal activity of promethazine; 17, 18 however, further investigations are needed to better understand these inhibitory effects on fungal cells. Thus, the aim of this study was to evaluate the effect of promethazine on the antifungal minimum inhibitory concentrations against planktonic cells and mature biofilms of C. tropicalis, as well as investigate its potential mechanisms of cell damage against this yeast species.
Methods

Isolates
Three C. tropicalis strains, two azole-resistant and one azole-susceptible, from urine, bronchoalveolar lavage, and tracheal aspirate, respectively, were used in this study. These isolates belong to the Culture Collection of the Specialized Medical Mycology Center, Brazil, where they are stored in saline solution at 4
• C. Strain identification was based on micromorphological features on cornmeal-Tween 80 agar, carbon and nitrogen assimilation, and carbon fermentation. 14 Single colonies were transferred to potato dextrose agar (PDA; Difco Laboratories, Detroit, MI, USA) for further assays. The phenotypical identification of the isolates was confirmed by matrix-assisted laser desorption-ionization time of flight (MALDI-TOF), as described by Lima-Neto et al. 19 The equipment used was MALDI-TOF Autoflex III 
Antifungal susceptibility testing
Minimum inhibitory concentrations (MICs) for amphotericin B, itraconazole, fluconazole, voriconazole, caspofungin, and promethazine were investigated by broth microdilution, according to the document M27-A3. 20 In order to determine the susceptibility of the planktonic cells, drugs were tested at concentrations ranging from 0.00390625 to 8 μg/ml for caspofungin, from 0.0625 to 16 μg/ml for amphotericin B, from 0.125 to 1024 for fluconazole, from 0.03125 to 512 μg/ml for itraconazole and voriconazole, and from 1 to 512 μg/ml for promethazine. The maximum or minimum concentration tested was adapted in order to determine the MICs. 
Biofilm susceptibility testing
For the evaluation of antifungal and promethazine susceptibility of sessile cells, biofilms were prepared as described by 
Evaluation of drug interaction
For the evaluation of the interaction between promethazine and the antifungal drugs, two sub-inhibitory concentrations of promethazine (16 and 8 μg/ml) were used in the analyses of each isolate. The antifungal susceptibility analysis of planktonic and sessile cells was performed, as previously described, with amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. Planktonic and sessile cells were incubated in the presence of the combination of promethazine and antifungals and incubated as above described. C. tropicalis ATCC 750 was also included as reference control strain. Afterward, the fractional inhibitory concentration index (FICI) was calculated for each promethazine combination, in order to evaluate drug interaction, which was considered to be synergistic when FICI ≤ 0.5, indifferent when 0.5 < FICI ≤ 4, and antagonistic when FICI > 4.
17,24
Confocal laser scanning microscopy (CLSM)
Biofilms of C. tropicalis were analyzed by CLSM, according to Brilhante et al. 14 Biofilms were formed directly on Thermanox TM coverslips, as described above, and different promethazine concentrations (32, 64, 128, 256, 512, 1024 , and 2048 μg/ml) were added to the samples. Biofilms were incubated for additional 48 h at 37
samples were incubated in RPMI 1640 only. After incubation, the Thermanox TM coverslips containing the adhered biofilm was transferred to a glass bottom Petri dish, where Live/Dead (Invitrogen TM151) fluorescent dye was added to cover the surface of the Thermanox TM coverslips. Afterward, the coverslips were evaluated under a Confocal Microscope (Nikon C2), at 488 nm for the detection of the SYTO 9 fluorescent dye (live cells) and at 561 nm for the detection of the propidium iodide (dead cells). 14 For image analyses, five equidistant points of the coverlips were submitted to Z-stacked capture of the images, for threedimensional image.
Scanning electron microscopy (SEM)
Biofilms of C. tropicalis were analyzed by SEM, as described in the previous section (CLSM). After incubation, biofilm supernatants were removed, and slides were washed with cacodylate buffer (0.15 M) twice. Biofilms were then covered with glutaraldehyde (2.5% in cacodylate buffer) and incubated at 4
• C overnight. After incubation, biofilms were washed twice with cacodylate buffer, and slides were dehydrated in ascending ethanol concentrations (50, 70, 80, 95, and 100%) twice, for 10 minutes each concentration. Slides were dried at room temperature and covered with hexamethyldisilazane for 30 minutes. Slides were dried overnight, coated with 10 nm of gold (Emitech Q150T), and observed with a FEI Inspect S50 scanning electron microscope, in the high vacuum mode at 15 kV, and images were processed with Photoshop (Adobe Systems, San Jose, CA, USA) software. 14 
Analysis of efflux pump activity by flow cytometry
The activity of efflux pumps was evaluated through flow cytometry by measuring the efflux of rhodamine 6G (R6G), as described by Jiang et al. 6 and Ivnitski-Steele et al., 25 with modifications. Yeast cells (10 6 ) in YEPD broth (1% yeast extract, 2% peptone, 2% dextrose) were suspended in 2 ml of PBS and incubated for 4 h at 30
• C with constant shaking to induce starvation. Starved cells were pre-incubated with promethazine at 8, 16, and 32 μg/ml, for 1 h. After incubation, 15 μM R6G (7.5 mM stock in DMSO) were added and incubated at 30
• C, for 20 min, in the dark. Then cells were washed with cold PBS, followed by the addition of glucose (20 mM in PBS) and incubation at 30
• C for 30 min. Afterward, cells were washed twice with cold sterile PBS. The fluorescence of each condition was immediately quantified using a FACSCalibur flow cytometer (BD Biosciences), with measurement of 10,000 cells per sample. Each assay was performed in triplicate and an azole-resistant C. parapsilosis, which is known to have an enhanced efflux activity, 26 was used as a positive control. Cellular debris was omitted from the analysis.
Determination of cell size/granulariry and membrane integrity
Cell size and granularity and membrane integrity of the fungal cells were evaluated by flow cytometry. Fungal strains were exposed to promethazine (64, 128, and 256 μg/ml), amphotericin B (control drug, 2 μg/ml), and fluconazole (control drug, 64 μg/ml) in RPMI medium at a final concentration of 10 6 cells/ml at 35 • C, for 2 and 4 h. Then, the cells were washed with PBS and incubated with 2 μg/ml propidium iodide (PI), in the dark, for 30 min. The cellular fluorescence was then determined using flow cytometry, in a FACSCalibur flow cytometer. Each assay was performed in triplicate. A total of 10,000 cells were evaluated per assay, with the cellular debris omitted from the analysis. 27 
Measurement of mitochondrial transmembrane potential ( ψm)
The mitochondrial transmembrane potential was determined by the retention of rhodamine 123 (Rho123) dye by fungal cells, after exposure to promethazine (64, 128, and 256 μg/ml), amphotericin B (control drug, 2 μg/ml), and fluconazole (control drug, 64 μg/ml) in RPMI medium at a final concentration of 10 6 cells/ml at 35 • C, for 2 and 4 h.
After exposure, the cells were washed with PBS incubated with 5 μg/ml Rho123, in the dark, at 37
• C for 30 min, and then washed twice with PBS. Their fluorescence was measured using flow cytometry, in a FACSCalibur flow cytometer. Each assay was performed in triplicate. A total of 10,000 cells were evaluated per experiment, and cellular debris was omitted from the analysis. 27 
Statistical analysis
All tests were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. P-values < .05 were considered statistically significant. The statistical analyses were performed with GraphPad Prism 7.0 (GraphPad Software, San Diego, CA, USA).
Results
Results regarding antifungal susceptibility tests are shown in Table 1 . Promethazine MIC and MFC were 64 μg/ml and 256 μg/ml, respectively. Fluconazole MICs against azole-resistant isolates were 256 and 512 μg/ml, voriconazole MICs were 32 and 64 μg/ml, and those for itraconazole were 128 μg/ml. Antifungal MICs against the azolesusceptible strain were 0.5, 0.0625, and 0.0625 μg/ml for fluconazole, itraconazole, and voriconazole, respectively. Amphotericin B and caspofungin MIC ranges were 0.25-1 μg/ml and 0.0078-0.0156 μg/ml, respectively.
The tested subinhibitory concentrations of promethazine (8 and 16 μg/ml) reduced the antifungal MICs and reversed the azole resistance phenotype of the two azole-resistant isolates. The MICs against the azole-resistant isolates reduced 64-to 128-fold for fluconazole and voriconazole and 1024-to 4096-fold for itraconazole (Table 1) . However, no synergistic interaction was observed for the combination of promethazine and azoles against the azole-susceptible strain and the reference strain (C. tropicalis ATCC 750), and antagonism was observed when promethazine was combined with fluconazole and voriconazole. Promethazine reduced the MICs for amphotericin B and caspofungin two-to 16-fold against the three C. tropicalis isolates and the reference strain. Paradoxical growth effect of caspofungin alone was only observed against the azole susceptible isolate, at 8 μg/ml. As for the combination of caspofungin and subinhibitory concentrations of promethazine (8 and 16 μg/ml), paradoxical growth was observed at 4 to 16 μg/ml of caspofungin against azole susceptible and resistant isolates ( Table 1) .
The killing activity of promethazine against C. tropicalis is shown in Figure 1 . Reduction in the number of cfu per milliliter was observed after 2 h of incubation of the yeast cells at different concentrations of the drug. At concentrations of 64, 128, and 256 μg/ml, the time required to kill 50% of the initial inoculum was 2 h. At the concentration four times the MIC (256 μg/ml), 99% reduction of live fungal cells was observed after 4 h of incubation, and no viable cells were observed after 12 h of incubation. Representative plots of mean ± standard deviation of colonyforming unit counts for the establishment of a time-kill curve for Candida tropicalis after exposure to promethazine at 32 μg/ml (square), 64 μg/ml (diamond), 128 μg/ml (circle), and 256 μg/ml (×). Drug-free growth control was also added for comparative purposes (triangle).
Regarding mature biofilm susceptibility, promethazine showed SMIC 50 of 128 μg/ml and SMIC 90 of 256 μg/ml, 2 times and 4 times the MIC for planktonic cells, respectively (Table 2 ). Antifungal SMIC 50 and SMIC 90 against C. tropicalis mature biofilm were 8 and 32 μg/ml for amphotericin B, <0.0625 μg/ml for caspofungin, >512 μg/ml for fluconazole and >128 μg/ml for itraconazole and voriconazole. Promethazine did not significantly modify the biofilm susceptibility to azoles, amphotericin B and caspofungin ( Table 2 ). The minimum caspofungin concentration that induced paradoxical biofilm growth decreased four-to eightfold in the presence of promethazine (Table 2) .
Alterations in biofilm structure and morphological changes in biofilm-associated cells after exposure to different promethazine concentrations were observed using CLSM (Fig. 2) and SEM (Fig. 3) . Fragmentation and reduction of viable cells and biomass were observed when biofilms were exposed to concentrations starting at 32 μg/ml of promethazine (MIC/2 against planktonic cells). Decrease in biofilm thickness was observed in all tested concentrations (Fig. 2) . Biomass increased at higher concentrations (1024 and 2048 μg/ml, Fig. 2 and 3) ; however, no live cells were observed (Fig. 2) . In addition, morphological changes in yeast cells were observed at 256 and 512 μg/ml, showing collapsed cells with wrinkled surface (Fig. 3) .
The uptake and efflux of R6G were quantified using flow cytometry to evaluate the activity of yeast efflux pumps and the effect of promethazine on this mechanism of survival and drug resistance. Initially, the efflux activity of the strains was assessed and one azole-resistant isolate showed significant decrease in intracellular fluorescence in the presence of glucose, when compared to the cells that were submitted to starvation (P < .05), demonstrating the efflux activity of this strain. Control strain (C. parapsilosis with enhanced efflux activity) also showed significant decrease in intracellular fluorescence in the presence of glucose in comparison with cells in starvation (P < .05). Afterward, the effect of promethazine was evaluated. Preincubation with promethazine (8, 16 , and 32 μg/ml) induced an increase in the mean intracellular fluorescence intensity of the azoleresistant isolate that showed efflux activity, when compared to the unexposed control in the presence of glucose (P < .05). However, for the azole-resistant strain that did not show efflux activity and for the azole-susceptible strain, preincubation with promethazine caused a little but significant decrease in the mean fluorescence intensity of the cells, when compared to the cells in starvation and the unexposed control in the presence of glucose (P < .05). Promethazine also induced a slight but significant increase in the mean intracellular fluorescence intensity of the control strain (P < .05).
A decrease in cell size/granularity was observed after 2 and 4 h incubation of C. tropicalis strains with promethazine at MIC, 2 × MIC, and 4 × MIC, similar to what was observed with amphotericin B (Fig. 4) . As shown in Figure 5 , a significant increase in the number of cells with plasma membrane damage was observed when yeast cells were exposed to different concentrations of promethazine, after 2 and 4 h of incubation, as demonstrated by the propidium iodide assay. Moreover, significant changes in the mitochondrial transmembrane potential were observed after 2 and 4 h of exposure to promethazine (Table 3 ). Rh123 fluorescence was lower in yeast cells exposed to promethazine, when compared to unexposed cells (P < .05). Decrease in Rh123 fluorescence was also observed when cells were exposed to amphotericin B.
Discussion
Azole resistance in C. tropicalis has become more common in the past years; 4, 5, 28 therefore, the quest for alternatives to overcome this obstacle has become relevant. In the present study, promethazine, a compound derived from phenothiazine, was evaluated against planktonic and sessile cells of azole-resistant C. tropicalis. The azole-resistance phenotype was altered when C. tropicalis isolates were treated with subinhibitory concentrations of promethazine, with azole MIC reductions reaching up to 2048-fold. Similar results were observed by Castelo-Branco et al. 17 and Brilhante et al. 29 who tested promethazine in combination with azole antifungals against azole-resistant Candida species, showing synergistic interactions. The authors suggested that this synergism was due to efflux pump inhibition by promethazine, an important mechanism of resistance in Candida species. Iatta et al. 30 suggested that the synergistic effect of promethazine and azoles against Malassezia species might be related to an increased efflux pump activity. This also seems to be the mechanism of drug interaction against C. tropicalis strains, since synergistic interactions between azoles and promethazine were only observed with azoleresistant isolates. Also, MIC reductions for amphotericin B and caspofungin were significant lower than those observed for azoles. Thus, possible mechanisms of cell damage caused by promethazine were assessed in order to better understand the interaction between promethazine and azole antifungals.
The time-kill assay demonstrated that cell death is observed as soon as 2 h after incubation with promethazine at MIC, 2 × MIC and 4 × MIC. Cell death rate increases as drug concentration increases, reaching 100% death at 4 times the MIC (256 μg/ml), after 12 h of incubation, in agreement with the MFC results. This result indicates a possible fungicidal mechanism of promethazine against C. tropicalis. 23 The mechanism of cell death of promethazine against C. tropicalis may be partially caused by damaged mitochondrial function, altered cell respiration and changes in cell structure, mainly membrane damage. Promethazine inhibited mature biofilms at concentrations twice the MIC for planktonic cells, showing an effective antibiofilm activity. Promethazine also promoted significant alterations in biofilm structure, decreasing the amount of hyphae and reducing its thickness. This structural change was more noticeable at lower concentrations of promethazine, while an increase in biomass was observed at the highest tested concentrations, although, live cells were not observed. The antibiofilm effects of promethazine alone may be of particular therapeutic interest, since biofilms are commonly associated with Candida infections and are inherently difficult to treat. 12 On the other hand, promethazine did not reduce the antifungal inhibitory concentrations against C. tropicalis mature biofilms, contrasting the results obtained against planktonic cells. Moreover, paradoxical growth effect of caspofungin on planktonic and sessile cells was detected at lower caspofungin concentration, when this antifungal was combined with promethazine. Paradoxical growth has been reported as an adaptive mechanism to overcome the effects of caspofungin, although the consequence of this effect on the treatment of Candida infections is still unclear.
14 Inhibition of fungal membrane efflux pumps possibly increases the susceptibility to antifungal drugs, 30 mainly azole drugs, as observed with Candida spp. 17, 26, 29 Thus, promethazine-induced efflux pump inhibition was evaluated using flow cytometry by measuring the efflux of R6G, which is a substrate of ATP-binding cassette (ABC) transporters, a class of membrane proteins that actively extrude azole drugs from the cells, conferring resistance. 25 Only one of the two azole-resistant isolates showed significantly higher efflux of R6G in the presence of glucose than that obtained for glucose-deprived cells, showing a patent efflux activity. As for the effects of promethazine against this azole-resistant isolate, when cells were preincubated for 1 h with promethazine, an increase in intracellular fluorescence was observed for this azole-resistant strain with enhanced efflux activity, demonstrating that promethazine hindered the efflux of R6G. This decrease in efflux activity caused by promethazine may be due to disturbances in cell membrane function or alterations in ATP production/metabolism. Changes in cell size/granularity were observed when cells were exposed to promethazine, which are associated with cell death. This alteration may be associated with the possible action of promethazine on cell membrane, as indicated by the analysis of membrane integrity using propidium iodide, a membrane-impermeant DNA-intercalating dye that is used to detect increased permeability of cell membranes, after antifungal treatment. 31 It is know that compounds that cause propidium iodide influx may directly affect fungal membranes, leading to fungal cell death. 32, 33 Alterations in membrane integrity and function could be another mechanism associated with the synergistic interaction between promethazine and azole antifungals. An interesting fact noticed is that, at higher concentrations of promethazine (256 μg/mL), a decrease in intracellular fluorescence is observed, indicating a decrease in plasma membrane damage. However, as observed in the time-kill curve assay, higher concentrations of promethazine start kill C. tropicalis cells after 2 h incubation. This fact indicates that membrane damage is not the major effect leading to death when C. tropicalis cells are exposed to high concentrations of promethazine. Moreover, the mitochondrial function was altered when C. tropicalis cells were treated with promethazine, suggesting the interference of this compound on Table 3 . Mean fluorescence intensity of rhodamine 123 (Rh123) in azole-resistant (n = 2) and azole-susceptible (n = 1) Candida tropicalis strains following exposure to promethazine. mitochondrial respiratory function. Decrease in Rh123 fluorescence, a cationic dye used to label mitochondria in living cells, is related to depolarization and de-energization of mitochondria, which leads to reduction in mitochondrial function. 34, 35 It is important to highlight that collapse of mitochondrial transmembrane potential can cause release of pro-apoptotic factors into the cytosol, leading to cell death. 27 Moreover, specific drugs that target fungal mitochondria could act in synergy with triazoles since this organelle acts as an energy conduit that is needed for many cell processes, including ergosterol biosynthesis. 36 In fact, a mitochondrial respiratory dysfunction leads to a decrease in NADPH and oxygen, which are respectively required for squalene dimerization and the conversion of squalene into 2,3 oxidosqualene, previous steps to that targeted by azoles. 37 Thus, the synergism between azoles and promethazine may also be associated with the action of the latter on fungal mitochondria and cell structure, leading to the decrease in efflux activity and ergosterol biosynthesis, resulting in the reduction of the antifungal MICs against azole-resistant strains. Alterations in mitochondrial function and cell morphology were observed in both azole-resistant and azolesusceptible strains. However, synergism between azoles and promethazine was only observed against azole-resistant isolates. This difference could be associated with differences in cell metabolism, as azole-resistant strains commonly present increased metabolic activity, often associated with increased respiration and gene overexpression, including ERG11, CDR and MDR. 6 Additionally, Denerdi et al. 38 reported that the combination of tacrolimus, a calcineurin inhibitor, also known for its efflux pump inhibiting properties, 39 and azoles showed high percentages of synergy against fluconazole-resistant C. glabrata but not against susceptible strains. Moreover, antagonistic interactions between tacrolimus and fluconazole were also observed against susceptible strains, similar to the results found in this study, where antagonistic interactions between promethazine and azoles (fluconazole and voriconazole) against the susceptible strain were observed.
Therefore, these results corroborate those found in our study, since no synergistic interactions between promethazine and azole drugs were observed. In summary, the present study demonstrated the synergistic effect between promethazine and azoles against resistant C. tropicalis isolates, reversing the resistance phenotype to all tested azoles. Promethazine presented an antibiofilm activity at a concentration 4 times the MIC against planktonic cells. Promethazine showed antifungal activity, altering cell size/granularity, membrane integrity and mitochondrial function, which are potential mechanisms of promethazine-mediated cell damage against C. tropicalis cells.
